4Greene FL,Stewart AK,Norton HJ.A new TNM staging strategy for node-positive (stage Ⅲ) colon cancer:an analysis of 50,042 patients.Ann surg,2002,236(4):416-421.
5French AJ,Sargent DJ,Burgart LJ,et al.Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer.Clin Cancer Res,2008,14(11):3408-3415.
6Thibodeau SN,Bren G,Schaid D.Microsatellite instability in cancer of the proximal colon.Science,1993,260(5109):816-819.
7Hailing KC,French AJ,McDonnell SK,et al.Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.J Natl Cancer Inst,1999,91(1):1295-1303.
8Gray RG,Barnwell J,Hills R,et al.QUASAR:A randomized study of adjuvant chemotherapy (CT) vs observation including 3238 colorectal cancer patients.Journal of Clinical Oncology,2004,22(14S):3501.
9Andre T,Boni C,Navarro M,et al.Improved overall survival with oxaliplatin,fluorouracil,and leucovorin as adjuvant treatment in stage Ⅱ or Ⅲ colon cancer in the MOSAIC trial.J Clin Oncol,2009,27(19):3109-3116.
10Tezcan D, Turkvatan A, Turkoglu MA, et al. Preoperative staging of colorectal cancer: Accuracy of single portal venous phase muhidetector computed tomography. Clin Imaging, 2013,37(6) :1048-1053.
